Languages SpokenEnglish Common ConditionsBased on the training and education, Dr. Ana Ciurea, MD may treat patients with the following conditions. Please always check with Dr. Ana Ciurea, MD directly about which exact conditions she treats. - Thigh Fat
- Stretched Ears
- Hypersensitive Skin
- Milia
- Turkey Neck
- Flat Butt
- Dandruff
- Cold Sores
- Psoriasis
- Dry Skin
- Itchy Skin
- Stretch Marks
- Damaged Hair
- Small Breasts
- Canker Sores
- Face Wrinkles
- Bruises
- Weak Chin
- Razor Bumps
- Crooked Nose
Prescribed MedicationsTriamcinolone Acetonide Ketoconazole Fluorouracil Hydrocortisone Hydroxyzine Mupirocin Clobetasol Propionate Doxycycline Hyclate Valacyclovir Clindamycin TreatmentsBased on the training and education, Dr. Ana Ciurea, MD may perform the following treatments. Please always check with Dr. Ana Ciurea, MD directly about which exact treatments he offers. - Juvederm
- Liquid Facelift
- Radiesse
- Non-Surgical Nose Job
- Thermage
Research & PublicationsApproximately 46% of Dermatologists in Houston, TX have available research publications Metastatic adenocarcinoma mimicking hidradenitis suppurativa. Imran T Baig, Quoc-Bao D Nguyen, Mary Alice Sallman Hickson, Ana Ciurea JAAD case reports 2022-08-01 Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Haider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, Doina Ivan, Priyadharsini Nagarajan, Jonathan L Curry, Ana M Ciurea, Adam I Rubin, Wen-Jen Hwu, Victor G Prieto, Phyu P Aung Archives of pathology & laboratory medicine 2021-08-01 Cutaneous Lesions of Multiple Myeloma of the Lower Extremity Masquerading as Squamous Cell Carcinoma. Courtney A Clutter, Savina Aneja, Doina Ivan, Ana Ciurea, Sirunya Silapunt Cureus 2020-11-03 Curative potential of hematopoietic stem cell transplantation for advanced psoriasis. Stefan O Ciurea, Panupong Hansrivijit, Ana M Ciurea, Sharon Hymes, Julianne Chen, Gabriela Rondon, Chitra Hosing, Uday Popat, Richard E Champlin American journal of hematology 2019-04-03 Surgical site identification with personal digital device: A prospective pilot study. Leon Chen, Adam M Parsons, Alexander B Aria, Ana M Ciurea, Anisha B Patel, Christopher Chan, John R Griffin, Tri H Nguyen, Michael R Migden Journal of the American Academy of Dermatology 2018-03-07 BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Kumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, Ana Ciurea, Sharon Hymes, Denái R Milton, Kenneth Y Tsai, Victor G Prieto, Carlos A Torres-Cabala, Jonathan L Curry Human pathology 2015-12-18 Case of vemurafenib-induced Sweet's syndrome. Jeffrey T Yorio, Steven R Mays, Ana M Ciurea, Philip R Cohen, Wei-Lien Wang, Wen-Jen Hwu, Nydia Gonzalez, Jessica L Richard, Kevin B Kim The Journal of dermatology 2014-03-12 Eruptive squamous cell carcinomas after vemurafenib therapy. Rana Mays, Jonathan Curry, Kevin Kim, Kenneth Tsai, Anita Arora, Farhan Khan, Marigdalia Ramirez-Fort, Ana Ciurea Journal of cutaneous medicine and surgery BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. Harina Vin, Sandra S Ojeda, Grace Ching, Marco L Leung, Vida Chitsazzadeh, David W Dwyer, Charles H Adelmann, Monica Restrepo, Kristen N Richards, Larissa R Stewart, Lili Du, Scarlett B Ferguson, Deepavali Chakravarti, Karin Ehrenreiter, Manuela Baccarini, Rosamaria Ruggieri, Jonathan L Curry, Kevin B Kim, Ana M Ciurea, Madeleine Duvic, Victor G Prieto, Stephen E Ullrich, Kevin N Dalby, Elsa R Flores, Kenneth Y Tsai eLife 2013-11-05 Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK. Harina Vin, Grace Ching, Sandra S Ojeda, Charles H Adelmann, Vida Chitsazzadeh, David W Dwyer, Haiching Ma, Karin Ehrenreiter, Manuela Baccarini, Rosamaria Ruggieri, Jonathan L Curry, Ana M Ciurea, Madeleine Duvic, Naifa L Busaidy, Nizar M Tannir, Kenneth Y Tsai Molecular cancer therapeutics 2013-10-29 Payments From Medical Companies(These can include payments from pharmaceutical companies, medical device companies, and other companies.) Dr. Ana Ciurea, MD has received over $3,638 in payments from medical companies (79% less than the average Dermatologist in Houston, TX) - Over $3,600 in payments for Consulting Fee (36% more than the average Dermatologist in Houston, TX)
- Over $38 in payments for Food and Beverage (99% less than the average Dermatologist in Houston, TX)
Merck Sharp & Dohme Corporation - $38.80 payment for Food and Beverage on 01/18/2020 Novartis Pharmaceuticals Corporation - $3,600.00 payment for Consulting Fee on 04/06/2018 Overview of What Patients Across the Web Are SayingThe feedback on Dr. Ana Ciurea leans strongly favorable, with its praise centered on the experience of being cared for by her. Patients describe a physician who is intelligent and unhurried, easy to talk with about personal health concerns, and skilled at putting people at ease. Comments return often to the thoroughness of her examinations and the clarity of her explanations, which appear to be a major source of the trust she inspires. One commendation goes further, describing her care as excellent in every respect and holding up her treatment of skin cancers as the strongest the writer has encountered. Taken together, the impression is of a clinician whose attentiveness and communication leave patients feeling confident in her judgment. The available commentary contains no criticism of her approach, though it says little about office logistics, scheduling, or follow-up arrangements, leaving those aspects of the visit largely unexamined.
Affiliated FacilitiesUniversity of Texas M D Anderson Cancer Center Houston Methodist Hospital
|